# DESCRIPTION

## CROSS REFERENCE

- claim benefit of prior applications

## BACKGROUND

- introduce CD8+ T cells and immune responses
- describe T cell exhaustion and its implications

## SUMMARY

- introduce T cell exhaustion and its effects
- describe SIRPα+CD8+ T cells and their characteristics
- outline methods for identifying and treating T cell exhaustion
- describe therapeutic approaches for expanding SIRPα+CD8+ T cells
- summarize potential applications in chronic infections and cancer

## DETAILED DESCRIPTION OF EMBODIMENTS

- introduce functional CD8+ T cells identification method
- describe T cell exhaustion
- explain characteristics of exhausted T cells
- discuss complete activation of T cells
- describe co-inhibitory signals and inhibitory receptors
- discuss exhausted T cells in cancer
- introduce targeted immunotherapies
- describe SIRPα protein and its variants
- define biological sample
- define obtaining and assaying a sample
- explain obtaining a biological sample
- discuss isolating a biological sample
- provide methods for isolating biological samples
- define terms
- describe immune responsiveness modulators
- explain PD-1 and PD-L1
- describe CTLA4
- discuss LAG3
- explain TIM3
- define infection and infectious agents
- describe therapeutically effective dose
- introduce anti-CD47 agents
- describe SIRPα polypeptide
- discuss high-affinity SIRPα reagents
- introduce anti-CD47 antibodies
- describe non-blocking anti-CD47 antibodies
- discuss CD47-blocking antibodies
- introduce anti-SIRPα antibodies
- describe specific anti-SIRPα antibodies
- introduce anti-SIRPα antibodies
- describe soluble CD47 polypeptides
- define treatment and prophylactic treatment
- describe inflicted cells and target cells
- define specific binding and affinity
- describe specific binding members
- define antibodies and immunoglobulins
- describe antibody fragments
- define epitope
- describe providing an analysis
- introduce methods for determining functional T cells
- describe identifying functional CD8+ T cells
- describe storing biological samples
- describe assaying biological samples
- define expression level and gene product
- describe determining expression level
- define RNA level measurement
- list methods for measuring RNA expression levels
- describe PCR-based methods
- describe nucleic acid sequencing methods
- outline protein level measurement
- describe methods for evaluating protein levels
- discuss clinical sample preparation
- describe cell staining and analysis
- outline use of affinity reagents
- describe comparison of differential analysis
- discuss chronic infections and pathogens
- outline treatment of infection and monitoring

### Kits

- describe kit components

## EXPERIMENTAL

- provide experimental details

### Example 1

- introduce CD8+ T cells during chronic exhaustion
- define SIRPα expression on CD8+ T cells
- motivate SIRPα as a novel cell surface marker
- summarize SIRPα expression on myeloid cells
- describe SIRPα's role in innate immunity
- analyze microarray data for SIRPα expression
- verify protein expression by flow cytometry
- examine SIRPα upregulation during acute and chronic Friend virus infection
- analyze kinetics of SIRPα upregulation during cell division
- describe distinct phenotype of SIRPα+ CD8+ T cells
- examine expression of additional markers on SIRPα+ CD8+ T cells
- analyze transcriptional profile of SIRPα+ CD8+ T cells
- identify genes upregulated in SIRPα+ CD8+ T cells
- associate SIRPα expression with in vivo effector function
- test cytolytic activity of SIRPα+ CD8+ T cells in vitro
- examine CD47+ targets in vivo
- analyze SIRPα expression on human CD8+ T cells during chronic HCV infection
- examine activation status of SIRPα+ CD8+ T cells
- stimulate human PBMCs to upregulate SIRPα
- expand SIRPα+ CD8+ T cells with PDL-1 blockade
- introduce SIRPα expression on CD8+ T cells
- describe SIRPα+ CD8+ T cell subset characteristics
- discuss SIRPα-CD47 interactions in cytolytic process
- analyze SIRPα+ CD8+ T cell gene expression profiles
- describe SIRPα+ CD8+ T cell functional properties
- discuss implications of SIRPα+ CD8+ T cells in immunotherapy
- introduce Materials and Methods section
- describe mouse and virus models used
- outline infection and tissue harvest procedures
- detail flow cytometry methods
- describe T cell adoptive transfer and in vitro CTL assays
- outline in vivo killing assay procedures
- describe in vivo anti-PD-L1 blockade experiments
- detail RNAseq analysis methods
- introduce HCV cohort and patient characteristics
- describe Phospho-CyTOF sample processing and staining
- outline in vitro stimulation of human CD8 T cells
- describe linear regression modeling methods
- detail statistical analysis of gene expression data
- conclude with implications of SIRPα+ CD8+ T cells in immunotherapy

